Azenta's top three insider shareholders as of September 29, 2026 are Stephen S Schwartz (Ceo, 446.54K shares), John Marotta (President And Ceo, 213.19K shares), Lindon G Robertson (Evp Chief Financial Officer, 121.08K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Stephen S Schwartz | Ceo | 446,536 | 0 | 446,536 | 20.5% | 17 Nov, 2023 |
| 2 | Jason Joseph | Svp, General Counsel, Secy. | 219,570 | 0 | 219,570 | 10.1% | 21 Nov, 2024 |
| 3 | John Marotta | President And Ceo | 213,194 | 0 | 213,194 | 9.8% | 03 Dec, 2025 |
| 4 | Lindon G Robertson | Evp Chief Financial Officer | 121,081 | 0 | 121,081 | 5.6% | 17 Nov, 2023 |
| 5 | Lawrence Y. Lin | Evp, Cfo And Treasurer | 110,199 | 0 | 110,199 | 5.1% | 16 Sep, 2026 |
| 6 | Krishna G. Palepu | Director | 105,393 | 0 | 105,393 | 4.8% | 15 Feb, 2023 |
| 7 | Joseph R Martin | Director | 85,175 | 0 | 85,175 | 3.9% | 07 Jun, 2023 |
| 8 | Ephraim Starr | Svp, Gen Counsel Secretary | 84,000 | 0 | 84,000 | 3.9% | 16 Sep, 2026 |
| 9 | David C Gray | Chief Strategy New Business | 74,868 | 0 | 74,868 | 3.4% | 20 Nov, 2023 |
| 10 | Robin Vacha | Svp, Gm Life Science Products | 62,250 | 0 | 62,250 | 2.9% | 02 Feb, 2024 |
| 11 | Robyn C Davis | Director | 60,749 | 0 | 60,749 | 2.8% | 11 Feb, 2025 |
| 12 | Ginger Zhou | Svp And Gm, Multiomics | 51,249 | 0 | 51,249 | 2.4% | 25 Nov, 2025 |
| 13 | Olga Pirogova | Svp And Chro | 47,225 | 0 | 47,225 | 2.2% | 16 Sep, 2026 |
| 14 | David Jarzynka | President, Semi Solutions | 46,315 | 0 | 46,315 | 2.1% | 22 Nov, 2021 |
| 15 | Martin D Madaus | Interim Ceo | 42,602 | 0 | 42,602 | 2.0% | 23 Sep, 2026 |
| 16 | Ellen M Zane | Director | 41,134 | 0 | 41,134 | 1.9% | 08 Aug, 2023 |
| 17 | Herman Cueto | Evp, Chief Financial Officer | 38,782 | 0 | 38,782 | 1.8% | 21 Nov, 2024 |
| 18 | David Dong Wang | Svp Gm, Sms | 33,452 | 0 | 33,452 | 1.5% | 05 Dec, 2024 |
| 19 | William E. Iii Martin | President Multiomics | 33,062 | 0 | 33,062 | 1.5% | 16 Sep, 2026 |
| 20 | Erica Mclaughlin | Director | 32,874 | 0 | 32,874 | 1.5% | 06 Feb, 2026 |
| 21 | Matthew Mcmanus | Evp Chief Operating Officer | 29,467 | 0 | 29,467 | 1.4% | 22 Aug, 2022 |
| 22 | Frank Casal | Director | 27,592 | 0 | 27,592 | 1.3% | 06 Feb, 2026 |
| 23 | David Pietrantoni | Principal Accounting Officer | 27,375 | 0 | 27,375 | 1.3% | 19 Nov, 2021 |
| 24 | Michael Rosenblatt | Director | 23,619 | 0 | 23,619 | 1.1% | 13 Feb, 2024 |
| 25 | William L Cornog | Director | 0 | 19,703 | 19,703 | 0.9% | 19 May, 2026 |
| 26 | Tina Susan Nova | Director | 19,376 | 0 | 19,376 | 0.9% | 06 Feb, 2026 |
| 27 | Alan J Malus | Director | 17,035 | 0 | 17,035 | 0.8% | 03 Jun, 2025 |
| 28 | Violetta Hughes | Vp, Chief Accounting Officer | 13,660 | 0 | 13,660 | 0.6% | 04 Feb, 2025 |
| 29 | Dipal Doshi | Director | 9,703 | 0 | 9,703 | 0.4% | 05 Feb, 2026 |
| 30 | Kimberly Crowley | Svp, Chief Hr Officer | 7,399 | 0 | 7,399 | 0.3% | 02 Feb, 2023 |
| 31 | Vandana Sriram | Svp Finance Corp. Controller | 6,356 | 0 | 6,356 | 0.3% | 02 Feb, 2023 |
| 32 | Quentin Koffey | Director | 5,035 | 0 | 5,035 | 0.2% | 11 Feb, 2025 |
| 33 | Erik J. Bello | Vp Chief Accounting Officer | 4,586 | 0 | 4,586 | 0.2% | 16 Sep, 2026 |
| 34 | Dorothy E Puhy | Director | 3,604 | 0 | 3,604 | 0.2% | 15 Feb, 2023 |
| 35 | Didier Hirsch | Director | 3,465 | 0 | 3,465 | 0.2% | 19 Nov, 2024 |
| 36 | Jesus Linda De | Chief Commercial Officer, Ls | 2,764 | 0 | 2,764 | 0.1% | 01 Aug, 2022 |
| 37 | Edward Peter Bousa | Director | 2,465 | 0 | 2,465 | 0.1% | 13 Feb, 2024 |
| 38 | Mitchell Coyne | Svp And Gm, Life Sciences Proj | 1,889 | 0 | 1,889 | 0.1% | 21 Nov, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 22 Sep, 2026 | Martin D Madaus | Interim Ceo | Disposed F | 1,456 | $34.28 | $49.91K | 42,602 | Direct |
| 09 Aug, 2026 | Olga Pirogova | Svp And Chro | Disposed F | 1,085 | $32.04 | $34.76K | 31,953 | Direct |
| 31 Jul, 2026 | Ephraim Starr | Svp, Gen Counsel Secretary | Acquired P | 335 | $24.17 | $8.10K | 68,728 | Direct |
| 18 May, 2026 | William L Cornog | Director | Acquired P | 10,000 | $16.38 | $163.80K | 19,703 | Indirect |
| 15 May, 2026 | Ephraim Starr | Svp, Gen Counsel Secretary | Disposed F | 3,621 | $16.02 | $58.01K | 68,393 | Direct |
| 28 Apr, 2026 | William E. Iii Martin | President Multiomics | Acquired A | 17,790 | $24.24 | $431.23K | 17,790 | Direct |
| 05 Feb, 2026 | Erica Mclaughlin | Director | Acquired A | 5,663 | $27.85 | $157.71K | 22,521 | Direct |
| 05 Feb, 2026 | Robyn C Davis | Director | Acquired A | 5,663 | — | — | 23,662 | Direct |
| 06 Feb, 2026 | Tina Susan Nova | Director | Acquired A | 5,663 | $27.85 | $157.71K | 15,772 | Direct |
| 05 Feb, 2026 | William L Cornog | Director | Acquired A | 5,663 | — | — | 5,663 | Direct |
| 05 Feb, 2026 | Frank Casal | Director | Acquired A | 7,243 | $27.85 | $201.72K | 21,803 | Direct |
| 05 Feb, 2026 | Martin D Madaus | Director | Acquired A | 5,663 | — | — | 9,703 | Direct |
| 05 Feb, 2026 | Dipal Doshi | Director | Acquired A | 5,663 | $27.85 | $157.71K | 9,703 | Direct |
| 24 Nov, 2025 | John Marotta | President And Ceo | Acquired A | 118,194 | $0.00 | $0 | 213,194 | Direct |
| 24 Nov, 2025 | John Marotta | President And Ceo | Acquired A | 122,269 | $0.00 | $0 | 217,269 | Direct |
| 24 Nov, 2025 | Ginger Zhou | Svp And Gm, Multiomics | Acquired A | 13,042 | $0.00 | $0 | 38,755 | Direct |
| 24 Nov, 2025 | Ephraim Starr | Svp, Gen Counsel Secretary | Acquired A | 34,235 | $0.00 | $0 | 72,014 | Direct |
| 24 Nov, 2025 | Lawrence Y. Lin | Evp, Cfo And Treasurer | Acquired A | 36,681 | $0.00 | $0 | 79,655 | Direct |
| 24 Nov, 2025 | Olga Pirogova | Svp And Chro | Acquired A | 16,303 | $0.00 | $0 | 33,038 | Direct |
| 14 Nov, 2025 | John Marotta | President And Ceo | Disposed F | 10,980 | $29.75 | $326.66K | 95,000 | Direct |